Details for New Drug Application (NDA): 018102
✉ Email this page to a colleague
NDA 018102 describes MEDROL, which is a drug marketed by Pharmacia And Upjohn and Pfizer and is included in three NDAs. It is available from five suppliers. Additional details are available on the MEDROL profile page.
The generic ingredient in MEDROL is methylprednisolone. There are forty drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the methylprednisolone profile page.
The generic ingredient in MEDROL is methylprednisolone. There are forty drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the methylprednisolone profile page.
Summary for 018102
| Tradename: | MEDROL |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | methylprednisolone acetate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | ENEMA;RECTAL | Strength | 40MG/BOT | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
